Clinical Study of ICP-192 in Solid Tumors Patients
Clinical trial NCT03758664 · UNKNOWN
Trial details
- NCT number
- NCT03758664
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2024-12-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.